Dexamethasone: Therapeutic potential, risks, and future projection during COVID-19 pandemic
S Noreen, I Maqbool, A Madni - European journal of pharmacology, 2021 - Elsevier
The current outbreak of novel COVID-19 challenges the development of an efficient
treatment plan as soon as possible. Several promising treatment options stand out as …
treatment plan as soon as possible. Several promising treatment options stand out as …
Potential adverse effects of dexamethasone therapy on COVID-19 patients: review and recommendations
F Chen, L Hao, S Zhu, X Yang, W Shi, K Zheng… - Infectious diseases and …, 2021 - Springer
In the context of the coronavirus disease 2019 (COVID-19) pandemic, the global healthcare
community has raced to find effective therapeutic agents against severe acute respiratory …
community has raced to find effective therapeutic agents against severe acute respiratory …
Dexamethasone for the treatment of coronavirus disease (COVID-19): a review
MH Ahmed, A Hassan - SN comprehensive clinical medicine, 2020 - Springer
Abstract The World Health Organization (WHO) declared COVID-19 (novel coronavirus) as a
global pandemic in the middle of March 2020, after the disease spread to more than 150 …
global pandemic in the middle of March 2020, after the disease spread to more than 150 …
Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a three-arm randomized clinical trial
N Toroghi, L Abbasian, A Nourian… - Pharmacological …, 2022 - Springer
Background and objectives Corticosteroids are commonly used in the treatment of
hospitalized patients with COVID-19. The goals of the present study were to compare the …
hospitalized patients with COVID-19. The goals of the present study were to compare the …
Role of dexamethasone and methylprednisolone corticosteroids in coronavirus disease 2019 hospitalized patients: a review
The WHO announced coronavirus disease 2019 (COVID-19) as a pandemic disease
globally on March 11, 2020, after it emerged in China. The emergence of COVID-19 has …
globally on March 11, 2020, after it emerged in China. The emergence of COVID-19 has …
Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled …
J Villar, JM Añón, C Ferrando, G Aguilar, T Muñoz… - Trials, 2020 - Springer
Background There are no specific generally accepted therapies for the coronavirus disease
2019 (COVID-19). The full spectrum of COVID-19 ranges from asymptomatic disease to mild …
2019 (COVID-19). The full spectrum of COVID-19 ranges from asymptomatic disease to mild …
No clinical benefit of high dose corticosteroid administration in patients with COVID-19: a preliminary report of a randomized clinical trial
The aim of this study was to evaluate the clinical effects of dexamethasone administration in
patients with mild to moderate acute respiratory distress syndrome (ARDS) due to …
patients with mild to moderate acute respiratory distress syndrome (ARDS) due to …
[PDF][PDF] Dexamethasone for COVID-19? Not so fast
TC Theoharides, P Conti - J Biol Regul Homeost Agents, 2020 - researchgate.net
Recent announcements indicated, without sharing any distinct published set of results, that
use of the corticosteroid dexamethasone in a large trial in the UK apparently reduced …
use of the corticosteroid dexamethasone in a large trial in the UK apparently reduced …
Dexamethasone in hospitalized patients with Covid-19
RECOVERY Collaborative Group - New England Journal of …, 2021 - Mass Medical Soc
Abstract Background Coronavirus disease 2019 (Covid-19) is associated with diffuse lung
damage. Glucocorticoids may modulate inflammation-mediated lung injury and thereby …
damage. Glucocorticoids may modulate inflammation-mediated lung injury and thereby …
Dexamethasone for severe COVID-19: how does it work at cellular and molecular levels?
The coronavirus disease 2019 (COVID-19) caused by infection of the severe respiratory
syndrome coronavirus-2 (SARS-CoV-2) significantly impacted human society. Recently, the …
syndrome coronavirus-2 (SARS-CoV-2) significantly impacted human society. Recently, the …